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model was established as follows: X1  =  maximum BWT [mm]; 
X2 = smoking [0: no, 1: yes]; X3 = BMI at diagnosis [m/kg
2]；X4 =  
previous perianal surgery [0: no, 1: yes]; X5  =  previous intestinal 
surgery [0: no, 1: es]; X6 = disease type (stricturing or penetrating 
disease); X7 = use of biologics; X8 = use of EEN; X9 = CRP at diag-
nosis). ROC curve and calculated AUC (94.7%) confirmed an ideal 
predictive ability of this model with a sensitivity of 75.92% and spe-
cificity of 95.81%. Nomogram was developed to simplify the use of 
predictive model in clinical daily practice. 
Conclusion: This prognostic model can effectively predict 1-year risk 
of CD-related intestinal surgery, which will assist in screening pro-
gressive CD patients and aid in tailoring therapeutic management.
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Background: ICONIC is the largest prospective multi-country (n = 
33) observational study assessing burden in adult ulcerative colitis 
(UC) patients under routine care. Both patient and physician assess-
ments of disease severity, activity and life impact were captured 
6 monthly up to 2 years. This local subanalysis evaluates baseline 
(BL) characteristics and the extent of agreement between patients 
and physicians in measures of disease activity in UK patients.
Methods: Adults with early UC (diagnosed ≤36  months) were 
enrolled irrespective of disease severity or treatment. Patient self-
assessments include disease severity, Pictorial Representation of 
Illness and Self-Measure (PRISM, a tool assessing perception of 
disease-associated suffering; lower scores indicate greater disease 
burden), Patient Health Questionnaire-9 (PHQ-9), Short inflam-
matory bowel disease Questionnaire (SIBDQ) and patient-modified 
Simple Clinical Colitis Activity Index (P-SCCAI). Physician assess-
ments include clinical parameters, PRISM, SCCAI. Correlation be-
tween PRISM and SIBDQ, PHQ-9 and SCCAI were evaluated by 
Spearman correlation. BL characteristics are based on observed data.
Results: BL characteristics of 63 UK patients in ICONIC are shown 
in Table 1.  From BL to 2-years, patient/physician PRISM was 
Figure 1. ROC curve of the training and testing data. (A) Predictive ability of this model was appraised with an AUC of 0.947, sensitivity of 75.92%, and specificity 
of 95.81%. (B) Discrimination of the validated model was estimated with an AUC of 0.937, sensitivity of 67.31%, and specificity of 97.55%. Abbreviations: 
PPV = positive predictive value; NPV = negative predictive value.
Figure 2. A prognostic nomogram for 1-year surgery in CD patients.
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moderately/strongly correlated with SIBDQ, PHQ-9, P-SCCAI or 
SCCAI (Table 2). For 62 patients with self and physician assess-
ments, the level of agreement on disease severity at BL (concordant 
pairs) was: mild 66.7%, moderate 27.8%, severe 45.5%, in remis-
sion 50.0%. The mean ± SD P-SCCAI and physician SCCAI values at 
2 years were 2.6 ± 2.6 and 1.5 ± 1.5, respectively; the measures were 
strongly correlated (Table 2). For patient/physician PRISM assess-
ments at 2 years, scores were 5.2 ± 2.6 and 5.2 ± 2.1, respectively, 
and were moderately/strongly correlated (Table 2).
Conclusion: Results from this subanalysis of ICONIC demonstrate 
persistently high UC disease burden over 2-years, despite treatment. 
EIMs were common and therefore awareness of potential EIM im-
pact is essential. PRISM, used for the first time in UC, was mod-
erately correlated with disease-specific measures (SIBDQ/SCCAI) 
and a general depression assessment (PHQ-9). Alignment between 
patients and physicians on disease activity/severity varied according 
to the instrument used but was greatest for SCCAI.
P209
Prospective validation of faecal calprotectin as a 
predictor of steroid failure in patients with acute 
severe colitis
P. SAHU*1, S. Kumar1, S. Jain1, N. Singh Mohil1, P. Sahni2, S. Pal2, 
N. Ranjan Das2, B. Nayak1, V. Sachdev1, M. Kumar Singh1, 
S. Kedia1, G. Makharia1, V. Ahuja1
1Department of Gastroenterology, All India Institute of Medical 
Sciences, New Delhi, India, 2Department of GI Surgery, All India 
Institute of Medical Sciences, New Delhi, India
Background: Optimal outcomes in acute severe colitis (ASC) are 
related to time-bound management based upon an early prediction 
of response to intravenous (IV) corticosteroids. We have demon-
strated good diagnostic accuracy of day 3 faecal calprotectin (FCP) 
in this setting. The present study intended to validate these findings 
in a different cohort.
Methods: This prospective cohort study included IV steroid naïve 
(for this episode) patients with ASC, satisfying Truelove and Witts’ 
criteria, hospitalised from September 2018 to August 2019. Patients 
were subjected to baseline sigmoidoscopy, day 1 and day 3 faecal cal-
protectin, baseline hemogram and biochemistry, and day 3 CRP. All 
patients received IV steroids after hospitalisation, and the primary 
outcome measure was steroid-failure defined as colectomy and/or 
rescue therapy with ciclosporin or infliximab during admission.
Results: Of 47 patients with ASC, eight were excluded (four received 
steroids outside, 2-directly taken for surgery/infliximab therapy, 
1-toxic megacolon on day 1, 1-infectious colitis), 39 were finally 
included [mean age−36.08  ± 12.58  years, male (30.7%)]. Fifteen 
patients (38.5%) failed IV steroids and required rescue therapy (10 
infliximab, 2 cyclosporine, four surgery). On univariate analysis, the 
factors significantly different between steroid responders and steroid 
failure included UCEIS >6 at baseline, Day 1 and Day 3 FCP, day 
5 stool frequency, day 5 ESR and CRP, and oxford criteria (Figure 
1). On multivariate analysis, only D3 FCP, UCEIS at baseline and 
Oxford criteria were significant predictors of steroid failure. Like the 
previous study, on ROC curve analysis, the day 3 FCP had similar 
diagnostic accuracy [AUC-0.86(0.75–0.98), and 1120.61 μg/g as a 
cut-off could predict steroid failure with 87% sensitivity and 79% 
specificity. Similarly, a combination of baseline UCEIS>6 and day 
3 FCP>1120.61 μg/g had 100% specificity and positive predictive 
value for steroid failure.
Conclusion: FCP retained its value as an objective predictor of 
steroid failure in ASC.
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Background: Inflammatory bowel disease (IBD) is a recognised 
risk factor for clostridium difficile infection (CDI), and CDI in an 
IBD patient is associated with higher morbidity and mortality. It is 
thought that factors including alterations in the gut microbiome, 
mucosal disruption and immunosuppression provide a synergistic 
environment for CDI to complicate an IBD flare. Despite this, there 
is conflicting evidence available on management. Our aim was to 
examine a series of recent cases to assess our own practice and sub-
sequent outcomes.
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